AMPH FY 2012 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMPHAmphastar Pharmaceuticals, Inc.

$832M

FY 2012 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$204M+72.6% YoY

Gross Profit

$90M44.2% margin

Operating Income

$25M12.4% margin

Net Income

$18M8.9% margin

EPS (Diluted)

$2.26

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$27M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$317M

Total Liabilities

$84M

Stockholders' Equity

$233M

Cash & Equivalents

$50M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$204M	$118M	+72.6%
Gross Profit	$90M	$28M	+221.3%
Operating Income	$25M	-$34M	+175.7%
Net Income	$18M	$8M	+133.4%